NC
CRNC icon

nVerses Capital’s Cerence CRNC Stock Holding History

nVerses Capital’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,000
Closed -$5.66K – 1070
2024
Q2 		$5.66K Buy
+2,000
New +$14.3K ﹤0.01% 950

Other funds holding CRNC

ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

nVerses Capital's CRNC Position: Q3 2024 in Review

nVerses Capital sold out of Cerence (CRNC) in Q3 2024, closing a stake of 2,000 shares — an estimated $5.66K sold.

nVerses Capital first reported a position in CRNC in Q2 2024 and held it in 1 quarter. The position peaked at $5.66K in Q2 2024. 157 funds tracked by Wall St. Rank hold CRNC as of Q3 2024.

  • nVerses Capital reported no remaining Cerence position as of Q3 2024 after selling out during the quarter.
  • nVerses Capital sold 2,000 Cerence shares in Q3 2024, an estimated $5.66K.
  • nVerses Capital first reported a position in Cerence in Q2 2024 and held it in 1 quarter.
  • nVerses Capital's Cerence position peaked at $5.66K in Q2 2024.
  • 157 funds tracked by Wall St. Rank held Cerence as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.